Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Seralutinib by Gossamer Bio for Pulmonary Arterial Hypertension: Likelihood of Approval
Seralutinib is under clinical development by Gossamer Bio and currently in Phase III for Pulmonary Arterial Hypertension. According to GlobalData,...
Data Insights
Seralutinib by Gossamer Bio for Pulmonary Arterial Hypertension: Likelihood of Approval
Seralutinib is under clinical development by Gossamer Bio and currently in Phase III for Pulmonary Arterial Hypertension. According to GlobalData,...